Oral Solid Dose (OSD) Tablets & Capsules facility Sale
Oral Solid Dose (OSD) Tablets & Capsules facility, 45 minutes from Boston, with $20 million in facility value / equipment. Asset Overview Opportunity
Manufacturing
Oral Solid Dose (OSD) Tablets & Capsules facility, 45 minutes from Boston, with $20 million in facility value / equipment. Asset Overview Opportunity
University-owned high-throughput, nanoparticle processing technology company. Continuous Manufacturing of Nanomedicines:
Ready for Immediate Acquisition
Self-amplifying RNA (saRNA) Virtual Biotech seeks VC investment to develop a pipeline of RNA therapeutics and vaccines.
Private-Equity owned, Phase III plasma-derived therapeutic company is ready to build the commercial facility with One Million Liter annual capacity, in Dallas Texas Looking to Raise Capital
Non-cGMP API Drug Development Starting Materials + API Pilot
Plant and cGMP CDMO: Ready for Immediate Acquisition with operations in Jaipur, India and Birmingham, Alabama
Marketed product in the GI space (idiopathic bowel syndrome, diarrhea, opioid induced constipation) available for acquisition. Client will also consider a distribution partnership.
Buy side client seeks to acquire manufacturing facilities in the US. Sterile manufacturing capabilities highly desired.
We appreciate your interest! Please get in touch and we will contact you directly.
Commercial Healthcare Partners
DISCLAIMER
The information contained in this website is for general information purposes only. The information is provided by Commercial Healthcare Partners and while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.